Get the Stockscreener App
4.47
3.04%
-0.14
Abcellera Biologics Inc stock is traded at $4.47, with a volume of 3.02M.
It is down -3.04% in the last 24 hours and up +4.68% over the past month.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
See More
Previous Close:
$4.61
Open:
$4.61
24h Volume:
3.02M
Relative Volume:
0.48
Market Cap:
$1.34B
Revenue:
$38.03M
Net Income/Loss:
$-146.40M
P/E Ratio:
-8.5962
EPS:
-0.52
Net Cash Flow:
$-121.38M
1W Performance:
+5.92%
1M Performance:
+4.68%
6M Performance:
+90.21%
1Y Performance:
+66.79%
1-Day Range:
$4.45
$4.6999
1-Week Range:
$4.085
$4.6999
52-Week Range:
$1.8906
$5.82
Abcellera Biologics Inc Stock (ABCL) Company Profile
Name
Abcellera Biologics Inc
Sector
Industry
Phone
(604) 559-9005
Address
150 W 4TH AVENUE, VANCOUVER
Compare ABCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
4.47 | 1.28B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | Leerink Partners | Outperform |
| Aug-20-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-22-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-06-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-13-23 | Resumed | Piper Sandler | Overweight |
| Feb-28-23 | Initiated | Cowen | Outperform |
| Dec-15-22 | Initiated | Goldman | Buy |
| Nov-16-22 | Initiated | Truist | Buy |
| Dec-21-21 | Initiated | The Benchmark Company | Buy |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Jan-05-21 | Initiated | BMO Capital Markets | Outperform |
| Jan-05-21 | Initiated | Berenberg | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Outperform |
| Jan-05-21 | Initiated | SVB Leerink | Outperform |
| Jan-05-21 | Initiated | Stifel | Buy |
View All
Abcellera Biologics Inc Stock (ABCL) Latest News
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer - BioSpace
AbCellera Biologics Appoints New Chief Medical Officer - TipRanks
AbCellera appoints Sarah Noonberg as first Chief Medical Officer - Investing.com
AbCellera appoints Sarah Noonberg as Chief Medical Officer - TipRanks
Abcellera appoints Dr. Sarah Noonberg as Chief Medical Officer - MarketScreener
3 Promising Penny Stocks With Market Caps Under $2B - simplywall.st
Bollinger Band Squeeze Points to Volatility in AbCellera Biologics Inc.2025 Market Sentiment & Capital Protection Trading Alerts - beatles.ru
Ichimoku Cloud Indicates Uncertainty Around AbCellera Biologics Inc.2025 Big Picture & Entry Point Confirmation Alerts - beatles.ru
Identifying reversal signals in AbCellera Biologics Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - Newser
Published on: 2025-09-06 12:54:41 - Newser
What the charts say about AbCellera Biologics Inc. todayJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
Will AbCellera Biologics Inc. outperform the marketFed Meeting & Daily Market Momentum Tracking - Newser
Published on: 2025-09-05 14:09:11 - Newser
Is AbCellera Biologics Inc. stock reversal real or fakeJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - Newser
AbCellera at Wells Fargo Conference: Strategic Pipeline Expansion By Investing.com - Investing.com Canada
Can AbCellera Biologics Inc. keep up with sector leadersOptions Play & Weekly Watchlist for Hot Stocks - خودرو بانک
Volume spikes in AbCellera Biologics Inc. stock – what they meanEarnings Beat & High Accuracy Swing Entry Alerts - Newser
How does AbCellera Biologics Inc. score in quality rankingsWeekly Investment Report & Weekly High Return Forecasts - خودرو بانک
Chart overlay techniques for tracking AbCellera Biologics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - Newser
What is AbCellera Biologics Inc. s P E ratio telling usDip Buying & Free Community Consensus Stock Picks - خودرو بانک
Is AbCellera Biologics Inc.’s ROIC above industry average2025 Price Momentum & Weekly Momentum Stock Picks - خودرو بانک
Trend analysis for AbCellera Biologics Inc. this weekJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Can a trend reversal in AbCellera Biologics Inc. lead to recoveryQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
How to recover losses in AbCellera Biologics Inc. stockJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Using economic indicators to assess AbCellera Biologics Inc. potentialAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Analyzing drawdowns of AbCellera Biologics Inc. with statistical toolsRisk Management & Reliable Volume Spike Trade Alerts - Newser
Applying Elliott Wave Theory to AbCellera Biologics Inc.July 2025 Rallies & Verified Entry Point Detection - Newser
Applying big data sentiment scoring on AbCellera Biologics Inc.Product Launch & Fast Momentum Entry Tips - Newser
Can machine learning forecast AbCellera Biologics Inc. recoveryJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
AbCellera Biologics Inc.’s volatility index tracking explainedAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Has AbCellera Biologics Inc. formed a bullish divergenceMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Chart based analysis of AbCellera Biologics Inc. trendsWeekly Gains Report & Community Consensus Trade Alerts - Newser
How to build a dashboard for AbCellera Biologics Inc. stockMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
What indicators show strength in AbCellera Biologics Inc.Trade Performance Summary & AI Optimized Trade Strategies - Newser
Is AbCellera Biologics Inc. affected by consumer sentiment2025 Major Catalysts & Verified Momentum Watchlists - خودرو بانک
Does AbCellera Biologics Inc. have consistent dividend growthWeekly Loss Report & Fast Momentum Stock Entry Tips - خودرو بانک
Is AbCellera Biologics Inc. part of any ETFProduct Launch & AI Based Buy and Sell Signals - خودرو بانک
Is AbCellera Biologics Inc. a momentum stockTrade Risk Report & Fast Entry and Exit Trade Plans - خودرو بانک
Real time scanner hits for AbCellera Biologics Inc. explainedIndex Update & Risk Controlled Swing Trade Alerts - Newser
Opinion: Defence spending must include health spending too - The Globe and Mail
Evaluating AbCellera Biologics Inc. with trendline analysis2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Breakout Watch: How does AbCellera Biologics Inc. score in quality rankingsWeekly Investment Recap & Risk Managed Investment Strategies - خودرو بانک
Applying chart zones and confluence areas to AbCellera Biologics Inc.Weekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Smart tools for monitoring AbCellera Biologics Inc.’s price actionWeekly Trade Recap & Fast Moving Market Watchlists - Newser
Is AbCellera Biologics Inc. on track to beat earningsIPO Watch & Proven Capital Preservation Methods - خودرو بانک
MACD Cross Could Confirm Trend in AbCellera Biologics Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
AbCellera Biologics Inc. stock trend outlook and recovery path2025 Top Gainers & Risk Controlled Daily Trade Plans - Newser
Detecting price anomalies in AbCellera Biologics Inc. with AIMarket Movement Recap & Technical Entry and Exit Tips - Newser
Abcellera Biologics Inc Stock (ABCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):